GSK to buy US biotech firm IDRx for up to $1.15 billion
2 days ago · British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of …
OFF
GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion
2 weeks from now
2 days ago · British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of …
reuters.com
OFF
GSK Enters Agreement To Acquire IDRx, Inc.
2 weeks from now
2 days ago · Under the terms of the agreement, GSK will acquire one hundred percent (100%) of the outstanding equity interests (including all options and other incentive equity) in IDRx for up …
gsk.com
OFF
GSK To Buy US Cancer Biotech IDRx For Up To $1.15 Billion
2 weeks from now
2 days ago · GSK Plc agreed to buy US biotech IDRx for as much as $1.15 billion to gain new cancer medicines.. The UK drugmaker will pay $1 billion upfront for IDRx, whose lead drug for …
bloomberg.com
OFF
GSK To Acquire IDRx For $1.15bn — Financier Worldwide
2 weeks from now
1 day ago · “Combining our experience to date with GSK’s expertise in GI cancers, global clinical development capability, and strong commercial presence in oncology will help to accelerate …
financierworldwide.com
OFF
GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion - U.S. News
2 weeks from now
2 days ago · (Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a …
usnews.com
OFF
GSK To Buy US Cancer Biotech IDRx For Up To US$1.15 Billion - 商业 …
2 weeks from now
2 days ago · GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion upfront for IDRx, whose lead drug …
businesstimes.com.sg
OFF
GSK To Buy U.S. Rare Tumor Specialist IDRx For Up To $1.15 Billion
2 weeks from now
2 days ago · GSK is buying privately-owned U.S. rare-tumor specialist IDRx for up to $1.15 billion, boosting its gastrointestinal cancer portfolio. The pharmaceutical giant said Monday that it will …
morningstar.com
OFF
GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion
2 weeks from now
2 days ago · British drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion payment. IDRx develops a treatment for …
indiatimes.com
OFF
GSK Buys US-based Rare Cancer Treatment Developer For Up To £1bn
2 weeks from now
2 days ago · Drugmaker GSK has agreed to pay up to 1.15 billion US dollars (£950 million) for a US-based biopharmaceutical company which is developing rare cancer therapies. GSK said …
independent.co.uk
OFF
GSK Nears $1 Billion Deal For Biotech Company IDRx - BNN …
2 weeks from now
Jan 8, 2025 · (Bloomberg) -- GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its …
bnnbloomberg.ca
OFF
Is GSK Prepping A $1bn Takeover Bid For IDRx? | Pharmaphorum
2 weeks from now
6 days ago · GSK confirms that it has agreed to buy US biotech IDRx and its KIT inhibitor for rare gastrointestinal tumours for $1bn upfront. News Lilly nets Scorpion cancer drug in $2.5bn …
pharmaphorum.com
OFF
GSK Confirms Plan To Buy Cancer Firm IDRx For $1bn
2 weeks from now
2 days ago · This morning, the UK pharma group confirmed it had signed an agreement to buy privately-held IDRx for $1 billion upfront, with another $150 million in payments to the biotech's …
pharmaphorum.com
OFF
GSK To Buy US Cancer Biotech IDRx For Up To $1.15 Billion - Deccan …
2 weeks from now
2 days ago · The UK drugmaker will pay $1 billion upfront for IDRx, whose lead drug for gastrointestinal tumors shows potential against mutations that currently leave patients with few …
deccanherald.com
OFF
GSK Nearing Deal To Acquire US Biotech IDRx For Up To $1 Billion
2 weeks from now
Jan 8, 2025 · -- GSK is in advanced discussions to acquire privately-owned US biotech company IDRx for up to $1 billion, the Financial Times reported Wednesday, citing people close to the …
marketscreener.com
OFF
GSK To Buy US Cancer Drug Firm IDRx For Up To $1.15bn
2 weeks from now
1 day ago · IDRx was launched in August 2022 by the entrepreneurs Ben Auspitz and Alexis Borisy, who have both invested in US biotech firms over the past two decades, to develop …
pressreader.com
OFF
GSK To Buy US Cancer Biotech IDRx For Up To $1.15 Billion (1)
2 weeks from now
2 days ago · GSK Plc agreed to buy US biotech IDRx for as much as $1.15 billion to gain new cancer medicines.. The UK drugmaker will pay $1 billion upfront for IDRx, whose lead drug for …
bloomberglaw.com
OFF
GSK In Talks To Buy U.S. Rare Tumor Specialist IDRx For Up To $1 ...
2 weeks from now
6 days ago · --Pharmaceutical giant GSK PLC is in talks to buy U.S. privately owned biotech company IDRx, which is developing a treatment for rare gastrointestinal tumors, for up to $1 …
morningstar.com
OFF
GSK To Buy US-based IDRx For Up To $1.15 Billion To Boost ...
2 weeks from now
2 days ago · GSK to Buy US-based IDRx for Up to $1.15 Billion to Boost Gastrointestinal Cancer Pipeline ... GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion Jan. 08 : MT ... It …
marketscreener.com
OFF
GSK Swooping To Buy US Biotech IDRx For $1bn - Report
2 weeks from now
Jan 8, 2025 · UK pharma giant GSK PLC is close to buying US biotech startup IDRx for $1 billion to boost its cancer drug business, the Financial Times has reported. Backed by a raft of …
proactiveinvestors.com
OFF
GSK Nears Deal To Acquire US Biotech IDRx For Up To $1 Billion
2 weeks from now
Jan 8, 2025 · -- GSK is in advanced discussions to acquire closely held US biotech company IDRx for up to $1 billion, the Financial Times reported Wednesday, citing people close to the …
marketscreener.com
OFF
GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion
2 weeks from now
2 days ago · (Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a …
investing.com
OFF
GSK To Buy US Biotech Firm IDRx For Up To $1.15 Billion - MSN
2 weeks from now
(Reuters) -British drugmaker GSK said on Monday that it would pay up to $1.15 billion to buy Boston-based biopharmaceutical firm IDRx, which is developing a treatment for a rare type of …
msn.com
OFF
GSK Nearing $1 Billion Deal To Acquire US Biotech IDRx, FT Reports
2 weeks from now
Jan 8, 2025 · GSK Reportedly in Advanced Talks to Buy US Biotech IDRx Jan. 09: ... GSK Nears Deal to Acquire US Biotech IDRx for Up to $1 Billion Jan. 08: MT ... The Companyâ s …
marketscreener.com
OFF
GSK To Buy U.S. Rare Tumor Specialist IDRx For Up To $1.15 Billion
2 weeks from now
2 days ago · GSK is buying privately-owned U.S. rare-tumor specialist IDRx for up to $1.15 billion, boosting its gastrointestinal cancer portfolio. The pharmaceutical giant said Monday that it will …
marketscreener.com
FAQs about GSK to buy US biotech firm IDRx for up to $1.15 billion Coupon?
Will GSK pay $115 billion to buy idrx?
Will GSK sell blenrep again?
Is idrx a Merck deal?
Could idrx help treat gastrointestinal stromal tumors?
Why are investors worried about GSK?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
